Abstract
This study aims at investigating the blood level of Cu, Zn, Se, and Cd in breast cancer patients and the association between such level and the frequency of micronucleated lymphocytes. Fifty stage I breast cancer patients were recruited for this study at the time of diagnosis and before receiving any treatment or surgery. The control group consisted of 150 normal females matched to the patients for age (± 5 years). The whole blood level of Cu, Zn, Se, and Cd was determined using spectrophotometry. The frequency of micronucleated lymphocytes in the blood was determined using the cytokinesis-block micronucleus assay. The level of Cu, Zn, and Se was significantly lower (p = 0.0006, <0.0001, and <0.0001, respectively) in breast cancer patients, as compared to controls. The level of Cd was significantly (p < 0.0001) higher in the patients, as compared to controls. The frequency of lymphocytes with one micronucleus was significantly (p < 0.0001) higher in the patients, as compared to controls. In breast cancer patients, the frequency of micronucleated lymphocytes showed different associations with different levels of these trace elements. High Cd, low Zn, low Se, and both high and low Cu levels were significantly associated with micronucleus formation in lymphocytes. A similar association was found in the normal control group only in relation to high Se and Cd levels. Breast cancer patients seem to have abnormal levels of Cu, Zn, Se, and Cd, and such abnormality is associated with micronucleus formation in lymphocytes.
Similar content being viewed by others
References
Durakovic A (2003) Undiagnosed illnesses and radioactive warfare. Croat Med J 44:520–532
El-basmy AA, Al-asfour A (2005) Kuwait Cancer Registry annual report
Rosenzweig AC, Sazinsky MH (2006) Structural insights into dioxygen-activating copper enzymes. Curr Opin Struc Biol 16:729–735
Ridge PG, Zhang Y, Gladyshev VN (2008) Comparative genomic analyses of copper transporters and cuproproteomes reveal evolutionary dynamics of copper utilization and its link to oxygen. PLoS One 3:e1378
Matoba S, Kang JG, Patino WD, Wragg A, Boehm M et al (2006) p53 regulates mitochondrial respiration. Science 312:1650–1653
Payne SL, Hendrix MJ, Kirschmann DA (2007) Paradoxical roles for lysyl oxidases in cancer—a prospect. J Cell Biochem 101:1338–1354
Singh V, Garg AN (1998) Trace element correlations in the blood of Indian women with breast cancer. Biol Trace Element Res 64:237–245
Ip C (1986) The chemopreventive role of selenium in carcinogenesis. Adv Exp Med Biol 206:431–447
Hu G, Han C, Wild CP, Hall J, Chen J (1992) Lack of effects of selenium on N-nitrosomethylbenzylamine-induced tumorigenesis, DNA methylation, and oncogene expression in rats and mice. Nutr Cancer 18:287–295
Schrauzer GN (2006) Interactive effects of selenium and chromium on mammary tumor development and growth in MMTV-infected female mice and their relevance to human cancer. Biol Trace Elem Res 109:281–292
Schrauzer GN (2008) Interactive effects of selenium and cadmium on mammary tumor development and growth in MMTV-infected female mice. A model study on the roles of cadmium and selenium in human breast cancer. Biol Trace Elem Res 123:27–34
Schrauzer GN (2008) Effects of selenium and low levels of lead on mammary tumor development and growth in MMTV-infected female mice. Biol Trace Elem Res 125:268–275
Lou J, He J, Zheng W, Jin L, Chen Z et al (2007) Investigating the genetic instability in the peripheral lymphocytes of 36 untreated lung cancer patients with comet assay and micronucleus assay. Mutat Res 617:104–110
Jacobson-kram D, Contrera JF (2007) Genetic toxicity assessment: employing the best science for human safety evaluation. Part I: early screening for potential human mutagens. Toxicol Sci 96:16–20
Lin Y, Keane M, Ensell M (2005) In vitro genotoxicity of exhaust emissions of diesel and gasoline engine vehicle on a united driving cycle. J Environ Monit 7:60–66
Mcdiarmid MA, Engelhardt SM, Oliver M, Gucer P, Wilson PD et al (2007) Health surveillance of Gulf War I veterans exposed to depleted uranium: updating the cohort. Health Phys 93:60–73
Kodama Y, Pawel D, Nakamura N, Preston D, Honda T et al (2001) Stable chromosome aberrations in atomic bomb survivors: results from 25 years of investigation. Radiat Res 156:337–346
Heuser VD, Erdtmann B, Kvitko K, Rohr P, Da Silva J (2007) Evaluation of genetic damage in Brazilian footwear-workers: biomarkers of exposure, effect, and susceptibility. Toxicology 232:235–247
Albertini RJ (2004) Mechanistic insights from biomarker studies: somatic mutations and rodent/human comparisons following exposure to a potential carcinogen. IARC Sci Publ 157:153–177
Montero R, Serrano L, Davila V, Segura Y, Arrieta A et al (2003) Metabolic polymorphisms and the micronucleus frequency in buccal epithelium of adolescents living in an urban environment. Environ Mol Mutagen 42:216–222
Van Delft JH, Steenwinkel MS, Van Asten JG, De Vogel N, Bruijntjes-rozier TC et al (2001) Biological monitoring the exposure to polycyclic aromatic hydrocarbons of coke oven workers in relation to smoking and genetic polymorphisms for GSTM1 and GSTT1. Ann Occup Hyg 45:395–408
Lucero L, Pastor S, Suarez S, Durban R, Gomez C et al (2000) Cytogenetic biomonitoring of Spanish greenhouse workers exposed to pesticides: micronuclei analysis in peripheral blood lymphocytes and buccal epithelial cells. Mutat Res 464:255–262
Van Poppel G, Verhagen H, Van’t Veer P, Van Bladeren PJ (1993) Markers for cytogenetic damage in smokers: associations with plasma antioxidants and glutathione S-transferase mu. Cancer Epidemiol Biomarkers Prev 2:441–447
Fenech M, Bonassi S, Turner J, Lando C, Ceppi M et al (2003) Intra- and interlaboratory variation in the scoring of micronuclei and nucleoplasmic bridges in binucleated human lymphocytes. Results of an international slide-scoring exercise by the HUMN project. Mutat Res 534:45–64
Fenech M, Holland N, Chang WP, Zeiger E, Bonassi S (1999) The Human MicroNucleus Project—an international collaborative study on the use of the micronucleus technique for measuring DNA damage in humans. Mutat Res 428:271–283
Fenech M, Crott J, Turner J, Brown S (1999) Necrosis, apoptosis, cytostasis and DNA damage in human lymphocytes measured simultaneously within the cytokinesis-block micronucleus assay: description of the method and results for hydrogen peroxide. Mutagenesis 14:605–612
Bonassi S, Znaor A, Ceppi M, Lando C, Chang WP et al (2007) An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis 28:625–631
Balasubramaniyan N, Subramanian S, Sekar N, Bhuvarahamurthy V, Govindasamy S (1994) Involvement of plasma copper, zinc and cadmium in human carcinoma of uterine cervix. Med Sci Res 22:475–476
Kuo HW, Chen SF, Wu CC, Chen DR, Lee JH (2002) Serum and tissue trace elements in patients with breast cancer in Taiwan. Biol Trace Elem Res 89:1–11
Centre for Disease Control (2005) Third national report on human exposure to environmental chemicals. Centre for Disease Control, Atlanta
Melton LA, Tracy ML, Moller G (1990) Screening trace elements and electrolytes in serum by inductively-coupled plasma emission spectrometry. Clin Chem 36:247–250
Fenech M (2006) Cytokinesis-block micronucleus assay evolves into a “cytome” assay of chromosomal instability, mitotic dysfunction and cell death. Mutat Res 600:58–66
Fenech M, Morley AA (1985) Measurement of micronuclei in lymphocytes. Mutat Res 147:29–36
Fenech M (2000) The in vitro micronucleus technique. Mutat Res 455:81–95
Zhang MB, He JL, Jin LF, Lu DQ (2002) Study of low-intensity 2450-MHz microwave exposure enhancing the genotoxic effects of mitomycin C using micronucleus test and comet assay in vitro. Biomed Environ Sci 15:283–290
Meyer F, Verreault R (1987) Erythrocyte selenium and breast cancer risk. Am J Epidemiol 125:917–919
Huang YL, Sheu JH, Lin T-H (1999) Association between oxidative stress and changes of trace elements in patients with breast cancer. Clin Biochem 32:131–136
Sharma K, Mittal DK, Kesarwani RC, Kamboj VP (1994) Diagnostic and prognostic significance of serum and tissue trace elements in breast malignancy. Ind J Med Sci 48:227–232
Fuchs AG, Mariotto R, De Lustig ES (1986) Serum and tissue copper content in two mammary adenocarcinomas with different biological behaviour. Eur J Cancer Clin Oncol 22:1347–1352
Linder MC, Moor JR, Wright K (1981) Ceruloplasmin assays in diagnosis and treatment of human lung, breast, and gastrointestinal cancers. J Nat Cancer Instit 67:263–275
Scanni A, Licciardello L, Trovato M, Tomirotii M, Biraghi M (1977) Serum copper and ceruloplasmin levels in patients with neoplasias localized in the stomach, large intestine or lung. Tumori 63:175–180
Chan A, Wong F, Arumanayagam M (1993) Serum ultrafiltrable copper, total copper and ceruloplasmin concentrations in gynecological carcinoma. Ann Clin Biochem 30:545–549
Zuo XL, Chen JM, Zhou X, Li XZ, Mei GY (2006) Levels of selenium, zinc, copper and antioxidant enzyme activity in patients with leukemia. Biol Trace Elem Res 114:41–54
Sattar N, Scott HR, Mcmillan DC, Talwar D, O’Reilly DSJ (1997) Acute-phase reactants and plasma trace element concentrations in non-small cell lung cancer patients and controls. Nutr Cancer 28:308–312
Fernandez-Banares F, Cabre E, Esteve M (2002) Serum selenium and risk of large size colorectal adenomas in a geographical area with a low selenium status. Am J Gastroenterol 97:2103–2108
Leitzmann MF, Stampfer MJ, Wu K, Colditz GA, Willett WC (2003) Zinc supplement use and risk of prostate cancer. J Natl Cancer Inst 95:1004–1007
Schrauzer GN, Molenaar T, Mead S, Kuehn K, Yamamoto H (1985) Selenium in the blood of Japanese and American women with and without breast cancer and fibrocystic disease. Jpn J Cancer Res 76:374–377
Ghadirian P, Maisonneuve P, Perret C (2000) A case control study of toenail selenium and cancer of the breast, colon, and prostate. Cancer Detection Prev 24:305–313
Van Den Brandt PA, Zeegers MPA, Bode P, Goldbohm RA (2003) Toenail selenium levels and the subsequent risk of prostate cancer: a prospective cohort study. Cancer Epidemiol Biomark Prev 12:866–887
Mark SD, Qiao YL, Dawsey SM (2000) Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst 92:1753–1763
Helzlsouer KJ, Comstock GW, Morris JS (1989) Selenium, lycopene, alpha-tocopherol, beta-carotene, retinol, and subsequent bladder cancer. Cancer Res 49:6144–6148
Zeegers MP, Goldbohm A, Bode P, Van Den Brandt PA (2002) Prediagnostic toenail selenium and risk of bladder cancer. Cancer Epidemiol Biomark Prev 11:1292–1297
Nomura AMY, Lee J, Stemmermann GN, Combs GF Jr (2000) Serum selenium and subsequent risk of prostate cancer. Cancer Epidemiol Biomark Prev 9:883–887
Van’t Veer P, Van Der Wielen RP, Kok F, Hermus RJ, Sturmans F (1990) Selenium in diet, blood and toenails in relation to breast cancer: a case–control study. Am J Epidemiol 131:987–994
Platz EA, Helzlsouer KJ, Hoffman SC, Morris JS, Baskett CK (2002) Prediagnostic toenail cadmium and zinc and subsequent prostate cancer risk. Prostate 52:288–296
Willett WC, Polk BF, Morris JS (1983) Prediagnostic serum selenium and risk of cancer. Lancet 2:130–134
Mcelroy JA, Shafer MM, Trentham-Dietz A, Hampton JM, Newcomb PA (2006) Cadmium exposure and breast cancer risk. J Natl Cancer Inst 98:869–873
Nagata C, Nagao Y, Shibuya C, Kashiki Y, Shimizu H (2005) Urinary cadmium and serum levels of estrogens and androgens in postmenopausal Japanese women. Cancer Epidemiol Biomarkers Prev 14:705–708
Lemen RA, Lee JS, Wagoner JK, Blejer HP (1976) Cancer mortality among cadmium production workers. Ann NY Acad Sci 271:273–279
West DW, Slattery ML, Robison LM, French TK, Mahoney AW (1991) Adult dietary intake and prostate cancer risk in Utah: a case–control study with special emphasis on aggressive tumors. Cancer Causes Control 2:85–94
Elinder CG, Kjellstrom T, Hogstedt C, Andersson K, Spang G (1985) Cancer mortality of cadmium workers. Br J Ind Med 42:651–655
Sorahan T (1987) Mortality from lung cancer among a cohort of nickel cadmium battery workers: 1946–84. Br J Ind Med 44:803–809
Norppa H (2004) Cytogenetic biomarkers and genetic polymorphisms. Toxicol Lett 149:309–334
Collins AR (1998) Molecular epidemiology in cancer research. Mol Aspects Med 19:359–432
Albertini RJ, Anderson D, Douglas GR, Hagmar L, Hemminki K (2000) IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. Mutat Res 463:111–172
Savage JRK (1993) Update on target theory as applied to chromosomal aberrations. Env Mol Mutagen 22:198–207
Evans HJ (1990) Cytogenetics overview. Prog Clin Biol Res 340B:301–323
Dellarco VL, Mavournin KH, Tice RR (1985) Aneuploidy and health risk assessment: current status and future directions. Environ Mutagen 7:405–424
Guttenbach M, Schmid M (1994) Exclusion of specific human chromosomes into micronuclei by 5-azacytidine treatment of lymphocyte cultures. Exp Cell Res 21:127–132
Fenech M (2007) Cytokinesis-block micronucleus cytome assay. Nat Protoc 2:1084–1104
Boffetta P, Van Der Hel O, Norppa H, Fabianova E, Fucic A (2007) Chromosomal aberrations and cancer risk: results of a cohort study from central Europe. Am J Epidemiol 165:36–43
Kops GJ, Weaver BA, Cleveland DW (2005) On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer 5:773–785
Poli G, Biasi F, Chiarpotto E (2004) Oxidative stress and cell signaling. Curr Med Chem 11:1163–1182
Chandra J, Samali A, Orrenius S (2000) Triggering and modulation of apoptosis by oxidative stress. Free Rad Med Biol 29:323–333
Floyd RA (1990) Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J 4:2587–2597
Valko M, Morris H, Cronin MTD (2005) Metals, toxicity and oxidative stress. Curr Med Chem 12:1161–1208
Merzenich H, Hartwig A, Ahrens W, Beyersmann D, Schlepegrell R (2001) Biomonitoring on carcinogenic metals and oxidative DNA damage in a cross-sectional study. Cancer Epidemiol Biomarkers Prev 10:515–522
Gate L, Paul J, Ba GN, Tew KD, Tapiero H (1999) Oxidative stress induced in pathologies: the role of antioxidants. Biomed Pharmcother 53:169–180
Gupte A, Mumper RJ (2009) Elevated copper and oxidative stress in cancer cells as a target for cancer treatment. Cancer Treat Rev 35:32–46
Jackson MJ (2009) Skeletal muscle aging: role of reactive oxygen species. Crit Care Med 37:S368–S371
Auld DS (2001) Zinc coordination sphere in biochemical zinc sites. Biometals 14:271–313
O’Connor JM (2001) Trace elements and DNA damage. Biochem Soc Trans 29:354–357
Leccia MT, Richard MJ, Favier A, Beani JC (1999) Zinc protects against ultraviolet A1-induced DNA damage and apoptosis in cultured human fibroblasts. Biol Trace Elem Res 69:177–190
Goldhaber SB (2003) Trace element risk assessment: essentiality vs. toxicity. Regul Toxicol Pharmacol 38:232–242
Torreggiani A, Domenech J, Orihuela R, Ferreri C, Atrian S (2009) Zinc and cadmium complexes of a plant metallothionein under radical stress: desulfurisation reactions associated with the formation of trans-lipids in model membranes. Chem Eur J 15:6015–6024
Hossain Z, Huq F (2002) Studies on the interaction between Cd(2+) ions and DNA. J Inorg Biochem 90:85–96
Mcmurray CT, Tainer JA (2003) Cancer, cadmium and genome integrity. Nat Genet 34:239–241
Waalkes MP (2000) Cadmium carcinogenesis in review. J Inorg Chem 79:241–244
Acknowledgment
The authors would like to thank Mrs. Smitha Adhip from the Department of Anatomy, Mrs. Alice Babu Mattappallil and Mr. Kanachu Isaac Mathew from the Department of surgery, and Dr. T.S. Kumar from the Department of Biochemistry for their technical help.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Saleh, F., Behbehani, A., Asfar, S. et al. Abnormal Blood Levels of Trace Elements and Metals, DNA Damage, and Breast Cancer in the State of Kuwait. Biol Trace Elem Res 141, 96–109 (2011). https://doi.org/10.1007/s12011-010-8724-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-010-8724-z